Prenylation inhibitors to treat proliferative renal disease.
Si
M S
MS
Imagawa
D K
DK
D000818:Animals; D004353:Drug Evaluation, Preclinical; D006084:Graft Rejection / Q000188:drug therapy* / Q000276:immunology; D006965:Hyperplasia; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D008213:Lymphocyte Activation / Q000187:drug effects*; D039821:Monoterpenes; D017035:Pravastatin / Q000494:pharmacology / Q000627:therapeutic use*; D017368:Protein Prenylation / Q000187:drug effects*; D051381:Rats; D013601:T-Lymphocytes / Q000187:drug effects*; D013729:Terpenes / Q000494:pharmacology / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D039821:Monoterpenes; D013729:Terpenes; C032208:perillyl alcohol; D017035:Pravastatin